Name | Walgreens #5081 |
---|---|
Organization Name | Walgreen Co |
Location | 4220 Lexington Ave S, Eagan, Minnesota 55123 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (651) 686-1090 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
What if you could design an adaptable, biomaterials-based model of an organ to track its immune response to any number of maladies, including cancer, transplant rejection and the Zika virus? The lab of Ankur Singh, assistant professor in the Sibley School of Mechanical and Aerospace Engineering, has asked - and begun to answer - that very question.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
Senate Democrats were bolstered Monday by the endorsement of the American Medical Association as they push for a final vote this week on their health overhaul legislation, Bloomberg reports. "The bill advances many of our priority issues for achieving the vision of a health system that works for patients and physicians," the AMA's president-elect, Dr. Cecil Wilson, said in endorsing the most recent version of the Senate bill, proposed over the weekend by Senate Majority Leader Harry Reid, D-Nev. (Salant and Donmoyer, 12/22).
Bladder cancer is the fourth-most-common cancer in men and one of the most expensive cancers to treat from diagnosis to death. After initial diagnosis and surgery, patients must return to the urologist at least yearly for a costly, time-consuming and uncomfortable bladder scan. Tumors recur in more than half of patients.
Researchers may have found a way to improve a common treatment for post-traumatic stress disorder by changing how the brain learns to respond less severely to fearful conditions, according to research published in Journal of Neuroscience.
› Verified 2 days ago
NPI Number | 1154337798 |
Organization Name | WALGREEN CO |
Doing Business As | WALGREENS #05081 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 4220 Lexington Ave S, Eagan, MN 55123 |
Phone Number | 651-686-1090 |
News Archive
What if you could design an adaptable, biomaterials-based model of an organ to track its immune response to any number of maladies, including cancer, transplant rejection and the Zika virus? The lab of Ankur Singh, assistant professor in the Sibley School of Mechanical and Aerospace Engineering, has asked - and begun to answer - that very question.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
Senate Democrats were bolstered Monday by the endorsement of the American Medical Association as they push for a final vote this week on their health overhaul legislation, Bloomberg reports. "The bill advances many of our priority issues for achieving the vision of a health system that works for patients and physicians," the AMA's president-elect, Dr. Cecil Wilson, said in endorsing the most recent version of the Senate bill, proposed over the weekend by Senate Majority Leader Harry Reid, D-Nev. (Salant and Donmoyer, 12/22).
Bladder cancer is the fourth-most-common cancer in men and one of the most expensive cancers to treat from diagnosis to death. After initial diagnosis and surgery, patients must return to the urologist at least yearly for a costly, time-consuming and uncomfortable bladder scan. Tumors recur in more than half of patients.
Researchers may have found a way to improve a common treatment for post-traumatic stress disorder by changing how the brain learns to respond less severely to fearful conditions, according to research published in Journal of Neuroscience.
› Verified 2 days ago
News Archive
What if you could design an adaptable, biomaterials-based model of an organ to track its immune response to any number of maladies, including cancer, transplant rejection and the Zika virus? The lab of Ankur Singh, assistant professor in the Sibley School of Mechanical and Aerospace Engineering, has asked - and begun to answer - that very question.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
Senate Democrats were bolstered Monday by the endorsement of the American Medical Association as they push for a final vote this week on their health overhaul legislation, Bloomberg reports. "The bill advances many of our priority issues for achieving the vision of a health system that works for patients and physicians," the AMA's president-elect, Dr. Cecil Wilson, said in endorsing the most recent version of the Senate bill, proposed over the weekend by Senate Majority Leader Harry Reid, D-Nev. (Salant and Donmoyer, 12/22).
Bladder cancer is the fourth-most-common cancer in men and one of the most expensive cancers to treat from diagnosis to death. After initial diagnosis and surgery, patients must return to the urologist at least yearly for a costly, time-consuming and uncomfortable bladder scan. Tumors recur in more than half of patients.
Researchers may have found a way to improve a common treatment for post-traumatic stress disorder by changing how the brain learns to respond less severely to fearful conditions, according to research published in Journal of Neuroscience.
› Verified 2 days ago
Cvs Pharmacy #06715 Type: Community/Retail Pharmacy Location: 4241 Jonny Cake Road, Eagan, Minnesota 55122 Phone: (651) 688-7041 | |
Cvs Pharmacy #16138 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2000 Cliff Lake Rd, Eagan, Minnesota 55122 Phone: (651) 688-8947 | |
Walgreens #5081 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4220 Lexington Ave S, Eagan, Minnesota 55123 Phone: (651) 686-1090 | |
Wal-mart Pharmacy 10-1786 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1360 Town Centre Dr, Eagan, Minnesota 55123 Phone: (651) 686-7431 | |
Hy-vee Pharmacy (1165) Type: Community/Retail Pharmacy Location: 1500 Central Park Commons Dr, Eagan, Minnesota 55121 Phone: (651) 405-3662 |